NCT06438211

Brief Summary

Pain after breast surgery can be quite severe and can significantly affect quality of life. By successfully treating acute pain, it is aimed to prevent the formation of pain memory and to ensure that chronic pain never occurs. It is known that by using regional techniques, the use of general anesthetics and opioids can be reduced and their harmful effects can be limited. In this study, it will be compared the analgesic effectiveness of superficial and deep serratus plane blocks in the postoperative acute and chronic periods.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
63

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 9, 2024

Completed
22 days until next milestone

First Posted

Study publicly available on registry

May 31, 2024

Completed
24 days until next milestone

Study Start

First participant enrolled

June 24, 2024

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 24, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 25, 2025

Completed
Last Updated

August 12, 2025

Status Verified

May 1, 2024

Enrollment Period

8 months

First QC Date

May 9, 2024

Last Update Submit

August 6, 2025

Conditions

Keywords

serratus anterior plane blocklocal anestheticregional anesthesiapostoperative analgesia

Outcome Measures

Primary Outcomes (1)

  • postoperative morphine consumption

    How much morphine the patient consumed in the first 24 hours postoperatively with a patient-controlled anesthesia device

    24 hours

Secondary Outcomes (1)

  • measuring pain scors

    24 hours

Study Arms (2)

Group I (superficial serratus anterior plane block)

ACTIVE COMPARATOR

Single-shot ultrasound (Esaote Mylab30) guided Superficial SAP block with 30 ml 0.25% bupivacain (Marcain 0.5%, Astra Zeneca, Turkey) at the T4- T5 ribs level (between the latissimus dorsi muscle and the serratus anterior muscle) was performed preoperatively to patients in the Superficial SAP group (Group I)

Procedure: superficial or deep serratus anterior plane block for mastectomy

Group II (deep serratus anterior plane block)

ACTIVE COMPARATOR

Single- shot ultrasound (Esaote Mylab30) guided Deep SAP block with 30 ml 0.25% bupivacain (Marcain 0.5%, Astra Zeneca, Turkey) at the T4- T5 ribs level ( between the serratus anterior muscle and the ribs) was performed preoperatively to patients in the Deep SAP group (Group I)

Procedure: superficial or deep serratus anterior plane block for mastectomy

Interventions

group I: superficial SAP Block for postoperative analgesia for mastectomy group II: deep SAP Block for postoperative analgesia for mastectomy

Group I (superficial serratus anterior plane block)Group II (deep serratus anterior plane block)

Eligibility Criteria

Age18 Years - 75 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsSince breast cancer is much more common in women than men and to ensure homogenization in the study, only female patients will be included.
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients who will undergo mastectomy surgery
  • patients who agreed to participate in the study
  • ASA I-II patients

You may not qualify if:

  • Patients planned for bilateral breast surgery
  • Patients who have had previous breast surgery
  • Patients with existing neuropathic pain or receiving treatment for neuropathic pain
  • Patients with psychiatric disorders
  • Patients with opioid addiction
  • Patients allergic to local anesthetics

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Erciyes

Kayseri, Talas, 38100, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Pain, PostoperativeAgnosia

Interventions

Mastectomy

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and SymptomsPerceptual DisordersNeurobehavioral ManifestationsNervous System Diseases

Intervention Hierarchy (Ancestors)

Surgical Procedures, Operative

Study Officials

  • Ayşe Ülgey, MD

    TC Erciyes University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor doctor

Study Record Dates

First Submitted

May 9, 2024

First Posted

May 31, 2024

Study Start

June 24, 2024

Primary Completion

February 24, 2025

Study Completion

May 25, 2025

Last Updated

August 12, 2025

Record last verified: 2024-05

Locations